AA
Anshul Agarwal
About Anshul Agarwal
Data last updated:
Anshul Agarwal is a Director at Safecon Lifesciences Private Limited (since 2016), Director at Radhashok Pharmachem Private Limited (since 2016) and Director at Meek Pharma Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Pharma, Agriculture and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹166 Cr; the largest is Safecon Lifesciences Private Limited at ₹87.00 Cr (FY 2025). Earlier, Anshul Agarwal was a Director at Wellcon Animal Health Private Limited (2015–2022) and Director at Vitapure Pharmacare Private Limited (2021–2022) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Safecon Lifesciences Private Limited U74999UP2016PTC083395 | Director | 21 May 2016 | 2016 | ₹87.00 Cr (FY 2025) | Active |
 Radhashok Pharmachem Private Limited U74999UP2016PTC082915 | Director | 04 May 2016 | 2016 | ₹68.78 Cr (FY 2025) | Active |
 Meek Pharma Private Limited U24230UR2005PTC000876 | Director | 07 Aug 2024 | 2005 | ₹7.27 Cr (FY 2025) | Active |
| Rachil Remedies Pvt Ltd U45202UP2006PTC090994 | Director | 01 Jun 2014 | 2006 | ₹3.19 Cr (FY 2025) | Active |
| Parthsanchi Agritech Llp ACI-1972 | Designated Partner | 19 Jul 2024 | 2024 | Active | |
| Radhashok Infratech Llp ACD-3231 | Designated Partner | 11 Oct 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wellcon Animal Health Private Limited U33111UP2015PTC067989 | Director | 02 Jan 2015 | 2015 | ₹53.37 Cr (FY 2025) | Active |
| Vitapure Pharmacare Private Limited U70102UP2011PTC043804 | Director | 09 Feb 2021 | 2011 | ₹13,560 (FY 2024) | Active |
| Safecon Pharmachemie Private Limited U24299UP2021PTC146481 | Director | 24 May 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anshul Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akash Sharma | 10859681 | Safecon Lifesciences Private Limited , Radhashok Pharmachem Private Limited and 2 more | Director |
| Ashok Kumar Agarwal | 03169551 | Safecon Lifesciences Private Limited , Meek Pharma Private Limited | Director |
| Sankalp Mittal | 10422591 | Radhashok Pharmachem Private Limited | Director |
| Ankur Agarwal | 00548259 | Meek Pharma Private Limited , Rachil Remedies Pvt Ltd and 2 more | Director |
| Deepak Kumar Agarwal | 00917053 | Meek Pharma Private Limited | Director |
| Sachin Kumar Agrawal | 10730615 | Meek Pharma Private Limited | Director |
| Anjul Agarwal | 06897907 | Rachil Remedies Pvt Ltd | Director |
| Manoj Jain | 00717904 | Rachil Remedies Pvt Ltd | Director |
| Pran Nath Mehta | 02215443 | Rachil Remedies Pvt Ltd | Director |
| Suchita Mittal | 06898069 | Rachil Remedies Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anshul Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anshul Agarwal
Anshul Agarwal currently holds 6 directorships: Safecon Lifesciences Private Limited (Director, since 21 May 2016, revenue ₹87.00 Cr (FY 2025)); Radhashok Pharmachem Private Limited (Director, since 04 May 2016, revenue ₹68.78 Cr (FY 2025)); Meek Pharma Private Limited (Director, since 07 Aug 2024, revenue ₹7.27 Cr (FY 2025)); Rachil Remedies Pvt Ltd (Director, since 01 Jun 2014, revenue ₹3.19 Cr (FY 2025)); Parthsanchi Agritech Llp (Designated Partner, since 19 Jul 2024); and 1 more.
Anshul Agarwal was first appointed on 01 Jun 2014 as Director at Rachil Remedies Pvt Ltd. The most recent appointment on record is 07 Aug 2024 at Meek Pharma Private Limited.
The 4 current companies of Anshul Agarwal that report revenue have a combined latest revenue of ₹166 Cr: Safecon Lifesciences Private Limited ₹87.00 Cr (FY 2025); Radhashok Pharmachem Private Limited ₹68.78 Cr (FY 2025); Meek Pharma Private Limited ₹7.27 Cr (FY 2025); Rachil Remedies Pvt Ltd ₹3.19 Cr (FY 2025).
Anshul Agarwal held 3 earlier board appointments: Wellcon Animal Health Private Limited (Director, 02 Jan 2015 to 23 Jun 2022); Vitapure Pharmacare Private Limited (Director, 09 Feb 2021 to 23 Jun 2022); Safecon Pharmachemie Private Limited (Director, 24 May 2021 to 23 Jun 2022).
The current boards of Anshul Agarwal's companies include Akash Sharma (Safecon Lifesciences Private Limited), Ashok Kumar Agarwal (Safecon Lifesciences Private Limited), Sankalp Mittal (Radhashok Pharmachem Private Limited), Ankur Agarwal (Meek Pharma Private Limited), Deepak Kumar Agarwal (Meek Pharma Private Limited), Sachin Kumar Agrawal (Meek Pharma Private Limited), among others.